Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
about
Effect of Necrosis on the miRNA-mRNA Regulatory Network in CRT-MG Human Astroglioma Cells.The Microenvironmental Landscape of Brain Tumors.Neutrophils in Gliomas.Association of baseline absolute neutrophil counts and survival in patients with metastatic colorectal cancer treated with second-line antiangiogenic therapies: exploratory analyses of the RAISE trial and validation in an electronic medical record d
P2860
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 July 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@en
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@nl
type
label
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@en
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@nl
prefLabel
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@en
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@nl
P2093
P2860
P50
P356
P1433
P1476
Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma.
@en
P2093
Aurélie Bertaut
Caroline Truntzer
Coureche Guillaume Kaderbhai
Klaus Luc Mourier
Marie Hélene Aubriot-Lorton
Rachid Madkouri
Romain Boidot
Wahlid Farah
P2860
P304
70948-70958
P356
10.18632/ONCOTARGET.10898
P407
P577
2016-07-28T00:00:00Z